Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients.
Recent studies have indicated an increased risk of dementia and Alzheimer's disease (AD) among people who consume proton pump inhibitors (PPIs), but the results of those studies are inconsistent. This meta-analysis aimed to explore the correction risk of dementia and AD among PPI users. The lit...
Main Authors: | Ya Qi Song, Yong Li, Su Li Zhang, Jie Gao, Shun Yi Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0219213 |
Similar Items
-
Proton pump inhibitors and dementia: what association?
by: Catarina Caetano, et al.
Published: (2023-05-01) -
Endophytic Fungus Isolated From Achyrocline satureioides Exhibits Selective Antiglioma Activity—The Role of Sch-642305
by: Nathalia Stark Pedra, et al.
Published: (2018-10-01) -
Proton Pump Inhibitors and Bone Health: An Update Narrative Review
by: Eric Lespessailles, et al.
Published: (2022-09-01) -
Regular proton pump inhibitor use and incident dementia: population-based cohort study
by: Peidong Zhang, et al.
Published: (2022-09-01) -
Proton-pump inhibitors
by: Vasudevan G. Naidoo
Published: (2015-05-01)